Executive Summary
Overview of the report
Study Methodology
Section I:
Background on mRNA Vaccine and Therapeutics
-
The rise of mRNA Technology
-
Impact of COVID in accelerating activity in the sector
-
National defense perspective
-
-
Increased investment from private and government sectors
-
-
Aging population and rise in cancer in young ages (Aggressive and difficult, also looking for noninvasive therapy for social activities)
-
-
Strict approval of government for therapeutics
Section II:
mRNA Vaccine and Therapeutics Market Overview
-
1. mRNA and its Therapeutic Applications
-
-
Explanation of mRNA and what is unique about the modality.
-
-
Overview of the development and therapeutic applications of mRNA-based drugs
-
-
Comparison of mRNA-based drugs with other biologic drugs
-
-
Advantages and disadvantages of mRNA-based drugs
-
2. Market Segmentation by type
-
-
Prophylactic Vaccines
-
-
Therapeutic Vaccines
-
-
Therapeutic Drugs
-
3. Market Segmentation by disease application
-
-
Oncology
-
-
Infectious disease
-
-
Rare genetic disease
-
3. Market Segment analysis by development stage (Development mapping David presented) : Texts and figure
-
-
Approved mRNA drugs and development and clinical landscape
-
-
Preclinical
-
-
Phase 1
-
-
Phase 2
-
-
Phase 3
Section III:
mRNA Manufacturing Technologies
-
Types of mRNA manufacturing technologies
-
LNP (Vehicle) CDMO
-
Starting product CDMO
-
Comparison of different mRNA manufacturing technologies
-
Advantages and disadvantages of each technology
-
Market share of each technology
Section IV:
Unique Considerations and Complexities in mRNA Development and Manufacturing
-
Overview of the unique considerations and complexities in mRNA development and manufacturing
-
Challenges in developing and manufacturing mRNA-based drugs, including stability, purity, potency, and immunogenicity
-
Impact of these challenges on the development and manufacturing process
-
Strategies and technologies used to overcome these challenges
Section V:
mRNA CDMOs Market Outlook
-
Market Overview
-
Growth drivers
-
Opportunities and challenges
Section VI:
Strategic Pricing Study
-
Manufacturing process
-
Strategic pricing
Section VII:
mRNA CDMOs Profile
-
Key segmentation analysis
-
Summary of Services
-
Individual profiles